MedTrace Logo

Clinical Evaluation of Polyherbal Coded Formulation Obesecure for Leptin Regulation and Obesity Management

NCT04443790 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2020-06-23

No results posted yet for this study

Summary

The study was designed to explore an alternative approach to reduce weight in human beings using a polyherbal formulation. A polyherbal formulation named as Obesecure was developed after screening of local medicinal flora. The formulation was further improved after pilot studies and Phase-I Clinical Trials.

Conditions

Interventions

DRUG

Leptin Human

Sponsors & Collaborators

  • Hamdard University

    collaborator OTHER

  • Government College University Faisalabad

    collaborator OTHER

  • Hafiz Muhammad Asif

    lead OTHER

Principal Investigators

  • Ejaz Mohiuddin, Ph.D · Hamdard University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-10
Primary Completion
2018-03-20
Completion
2018-05-20

Countries

  • Pakistan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04443790 on ClinicalTrials.gov